These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30275180)

  • 1. Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer.
    Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S
    Anticancer Res; 2018 Oct; 38(10):5627-5634. PubMed ID: 30275180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in the Molecular Landscape of Cancer.
    Heath EI; Lynce F; Xiu J; Ellerbrock A; Reddy SK; Obeid E; Liu SV; Bollig-Fischer A; Separovic D; Vanderwalde A
    Anticancer Res; 2018 Apr; 38(4):2235-2240. PubMed ID: 29599344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed.
    Mitchell MI; Ben-Dov IZ; Ye K; Liu C; Shi M; Sadoughi A; Shah C; Siddiqui T; Okorozo A; Gutierrez M; Unawane R; Biamonte L; Parikh K; Spivack S; Loudig O
    J Extracell Vesicles; 2024 Apr; 13(4):e12440. PubMed ID: 38659349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency of NRAS mutation in stool samples of Iranian colorectal cancers compared to Finnish patients.
    Saberi F; Youssef O; Kokkola A; Khodadoostan M; Puolakkainen P; Salehi R; Knuutila S
    J Res Med Sci; 2024; 29():4. PubMed ID: 38524743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraction and characterization of exosomes from the exhaled breath condensate and sputum of lung cancer patients and vulnerable tobacco consumers-potential noninvasive diagnostic biomarker source.
    Bano A; Yadav P; Sharma M; Verma D; Vats R; Chaudhry D; Kumar P; Bhardwaj R
    J Breath Res; 2024 Jul; 18(4):. PubMed ID: 38988301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-small cell lung carcinoma with clear cell features: a clinicopathologic, immunohistochemical, and molecular study of 31 cases.
    Suster DI; Ronen N; Mejbel HA; Harada S; Mackinnon AC; Suster S
    Virchows Arch; 2024 Jul; 485(1):83-96. PubMed ID: 38814477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.
    Zhang JW; Qin T; Hong SD; Zhang J; Fang WF; Zhao YY; Yang YP; Xue C; Huang Y; Zhao HY; Ma YX; Hu ZH; Huang PY; Zhang L
    Chin J Cancer; 2015 Apr; 34(4):177-83. PubMed ID: 25963410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next-generation sequencing technique.
    Manabe S; Kasajima R; Murakami S; Miyagi Y; Yokose T; Kondo T; Saito H; Ito H; Kaneko T; Yamada K
    Thorac Cancer; 2020 Aug; 11(8):2262-2269. PubMed ID: 32578376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting.
    Kumbrink J; Demes MC; Jeroch J; Bräuninger A; Hartung K; Gerstenmaier U; Marienfeld R; Hillmer A; Bohn N; Lehning C; Ferch F; Wild P; Gattenlöhner S; Möller P; Klauschen F; Jung A
    Pathol Oncol Res; 2024; 30():1611590. PubMed ID: 38605929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype-Phenotype Correlations.
    Schmidt VF; Kapp FG; Goldann C; Huthmann L; Cucuruz B; Brill R; Vielsmeier V; Seebauer CT; Michel AJ; Seidensticker M; Uller W; Weiß JBW; Sint A; Häberle B; Haehl J; Wagner A; Cordes J; Holm A; Schanze D; Ricke J; Kimm MA; Wohlgemuth WA; Zenker M; Wildgruber M;
    J Am Heart Assoc; 2024 Apr; 13(8):e033287. PubMed ID: 38563363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The research advances in Kirsten rat sarcoma viral oncogene homolog (KRAS)-related cancer during 2013 to 2022: a scientometric analysis.
    Huang Y; Zheng D; Zhou Z; Wang H; Li Y; Zheng H; Tan J; Wu J; Yang Q; Tian H; Lin L; Li Z; Li T
    Front Oncol; 2024; 14():1345737. PubMed ID: 38706597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiles of Indonesian colorectal cancer patients.
    Abdullah M; Meilany S; Trimarsanto H; Malik SG; Sukartini N; Idrus F; Nursyirwan SA; Muzellina VN; Pribadi RR; Utari AP; Maulahela H; Syam AF
    F1000Res; 2022; 11():443. PubMed ID: 37125020
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted next-generation sequencing of 491 lung cancers in clinical practice: Implications for future detection strategy and targeted therapy.
    Liu XD; Zhang Y; He HY
    Heliyon; 2024 Mar; 10(6):e27591. PubMed ID: 38496837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive detection of orthotopic human lung tumors by microRNA expression profiling of mouse exhaled breath condensates and exhaled extracellular vesicles.
    Mitchell MI; Ben-Dov IZ; Liu C; Wang T; Hazan RB; Bauer TL; Zakrzewski J; Donnelly K; Chow K; Ma J; Loudig O
    Extracell Vesicles Circ Nucl Acids; 2024; 5(1):138-164. PubMed ID: 38863869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing.
    Stead LF; Egan P; Devery A; Conway C; Daly C; Berri S; Wood H; Belvedere O; Papagiannopoulos K; Ryan A; Rabbitts P
    PLoS One; 2013; 8(11):e78823. PubMed ID: 24244370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.
    Chalela R; Curull V; Enríquez C; Pijuan L; Bellosillo B; Gea J
    J Thorac Dis; 2017 Jul; 9(7):2142-2158. PubMed ID: 28840016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic driver mutations in non-small cell lung cancer: Past, present and future.
    Chevallier M; Borgeaud M; Addeo A; Friedlaender A
    World J Clin Oncol; 2021 Apr; 12(4):217-237. PubMed ID: 33959476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of molecular analysis results determined by next-generation sequencing to immunohistochemical indicators and clinicopathological parameters in prostate adenocarcinomas.
    Balta MÇ; Erdoğdu İH; Oktay E; Çulhac N
    Indian J Pathol Microbiol; 2024 Apr; 67(2):267-274. PubMed ID: 38427749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Cancer: One Disease or Many.
    O'Brien TD; Jia P; Aldrich MC; Zhao Z
    Hum Hered; 2018; 83(2):65-70. PubMed ID: 29864749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Lung Cancer Treatments and Eye Metastasis.
    Zarogoulidis P; Baka S; Labaki S; Lazaridis G; Trakada G
    Med Hypothesis Discov Innov Ophthalmol; 2017; 6(1):10-13. PubMed ID: 28428969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.